Skip to content

Effect of thoracic paravertebral nerve block with liposomal bupivacaine on hemodynamics and postoperative analgesia in patients undergoing non-stop coronary artery bypass grafting

Effect of thoracic paravertebral nerve block with liposomal bupivacaine on hemodynamics and postoperative analgesia in patients undergoing non-stop coronary artery bypass grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082668
Enrollment
Unknown
Registered
2024-04-03
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Group LB:In group LB, Bilateral thoracic paravertebral nerves were blocked with liposomal bupivacaine under ultrasound guidance before anesthesia induction
Group R:In group R, Bilateral thoracic paravertebral nerves were blocked with ropivacaine hydrochloride under ultrasound guidance before anesthesia induction

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)Age 45-70 years old, gender unlimited;(2) Coronary angiography confirmed multi-vessel lesions with indications for surgery, NYHA cardiac function class II or III, and left ventricular ejection fraction (LVEF) >50%; (3) Postoperative ICU admission; (4) Planned hospitalization for 24 hours after surgery; (5) Willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Refusal to participate; (2) Contraindications to paravertebral nerve block (including thoracic infection, infectious diseases of the skin and soft tissues at the puncture site, or tumors,unclear or abnormal anatomical location of the puncture site, unclear body surface identification, coagulation dysfunction and local anesthetic allergy) (3) Cardiac surgery or second cardiac surgery history, acute cardiac tamponade and myocardial infarction, severe sinus bradycardia, atrioventricular block or sick sinus syndrome; (4) Emergency surgery; (5) Intraoperative conversion to coronary artery bypass grafting under cardiopulmonary bypass; (6) Chronic lung disease in the past, pulse oximetry < 90% without oxygen; (7) Severe hepatic dysfunction; (8) Severe renal insufficiency; (9) Stroke, schizophrenia, depression, Parkinson's disease, epilepsy or dementia; (10) Unable to communicate due to illiteracy, speech impairment, or significant hearing or vision impairment;

Design outcomes

Primary

MeasureTime frame
Postoperative myocardial markers and stress indicators;MAP and HR at different time points in the perioperative period;Perioperative opioid use;Postoperative NRS scores;

Secondary

MeasureTime frame
Duration of postoperative mechanical ventilation;ICU stay time;Hospital stay time;Hospitalization expenses;

Countries

China

Contacts

Public ContactYu Chen

The First Affiliated Hospital of Nanjing Medical University

chenyu_njmu@126.com+86 139 5103 3928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026